Cargando…
Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous Coronary Intervention: Which Is More Efficient and Safer?
Introduction: Patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) treated with percutaneous coronary intervention (PCI) are at high risk of bleeding and thromboembolic events. Thus, optimal treatment strategies in this challenging subset have been controversial. Herein, we aim t...
Autores principales: | Bachorski, Witold, Bychowski, Jakub, Gruchała, Marcin, Jaguszewski, Miłosz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572308/ https://www.ncbi.nlm.nih.gov/pubmed/37835798 http://dx.doi.org/10.3390/diagnostics13193055 |
Ejemplares similares
-
The focal takotsubo syndrome presenting with the snail-like left ventricle
por: Genc, Alicja, et al.
Publicado: (2021) -
Inquiries about a patient with a “snail-like” takotsubo syndrome variant. Authors’ reply
por: Genc, Alicja, et al.
Publicado: (2022) -
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
por: Jacobs, M. S., et al.
Publicado: (2018) -
Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
por: Kwak, Soongu, et al.
Publicado: (2019) -
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
por: Huisman, M. V.
Publicado: (2021)